Skip to main content
. 2022 Oct 11;12:17012. doi: 10.1038/s41598-022-21394-y

Table 2.

Top results of integrative enrichment analysis with IPA.

Diseases or functions annotation p-value Activation z-score Metabolites Proteins Phospho-proteins
Abnormality of cerebral cortex 8.3E−5  − 1.951 Glutamate* CD81, CELSR3, CYGB, F12, TNR* VIM*
Apoptosis 6.1E−5  − 1.458 O-acetyl carnitine*, alpha-tocopherol*, choline, ethanolamine*, glycine*, glutamate*, glutamine*, ethanolamine phosphate*, S-adenosylmethionine* B2M, CYGB, GHRH, HAPLN1*, IFIT3, ISG15, MTSS1*, PCP4*, SERPINB9, SPP1, STAR, VCAN ADAM10*, EIF4B*, HNRNPC*, MAP2K4, PPP1R2*, SPP1*, UBE2V2*, VIM*, ZFP36L1
Synthesis of protein 1.9E−7  − 1.315 Creatine*, glycine*, aspartate*, glutamate* IGFBP2, ISG15, SPP1 EEF2*, EIF4B*, LARP1, MAP2K4, PPP1R2*, SPP1*, VIM*, ZFP36L1
Metabolism of protein 7.9E−08  − 0.781 Creatine*, glycine*, aspartate*, glutamate* B2M, CD81, F12, F9, IGFBP2, ISG15, SPP1, VCAN ADAM10*, EEF2*, EIF4B*, LARP1, LONP1*, MAP2K4, PPP1R2*, SPP1*, VIM*, ZFP36L1
Synthesis of amino acids 4.4E−5  − 0.555 Creatine*, glycine*, aspartate*, glutamate* VCAN
Transmembrane potential of mitochondria 7.4E−5 0.958 Glutamate*, S-adenosylmethionine* B2M, STAR LONP1*, MAP2K4, VIM*
Conversion of lipid 2.0E−7 1.476 O-acetyl carnitine*, alpha-tocopherol*, creatine*, glycine*, guanidoacetic acid*, glutamate*, glutamine*, S-adenosylmethionine* CYGB, STAR
Peroxidation of lipid 2.6E−08 1.82 O-acetyl carnitine*, alpha-tocopherol*, creatine*, glycine*, guanidoacetic acid*, glutamate*, glutamine*, S-adenosylmethionine* CYGB
Uptake of amino acids 6.5E−6 2.173 Choline, glycine*, guanidoacetic acid*, aspartate*, glutamate* TNR*
Progressive neurological disorder 6.0E−6 2.186 O-acetyl carnitine*, choline, creatine*, glutamate*, N-acetylaspartic acid*, S-adenosylmethionine*, glycerophosphocholine* CHCHD2, F12, IGFBP2, ISG15, SPP1, STAR, TNR* ADAM10*, EEF2*, SPP1*, VIM*, ZFP36L1

*Indicates molecules with |log2(ratio)|> 1.5.